BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
79 hedge funds and large institutions have $42M invested in Bellicum Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 21 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
-15
Holders Change %
-15.96%
% of All Funds
1.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
26
Reduced
21
Closed
24
Calls
$31K
Puts
$40K
Net Calls
-$9K
Net Calls Change
+$1K
Top Buyers
| 1 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
$3.58M |
| 2 |
NAMA
Nikko Asset Management Americas
New York
|
$3.58M |
| 3 |
Renaissance Technologies
New York
|
$2.66M |
| 4 |
Goldman Sachs
New York
|
$1.14M |
| 5 |
Jane Street
New York
|
$411K |
Top Sellers
| 1 |
BlackRock
New York
|
$2.15M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
$0 |
| 3 |
JPMorgan Chase & Co
New York
|
$6.73M |
| 4 |
State Street
Boston,
Massachusetts
|
$92K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$3.19M |
